Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alibaba | 4.17% | $28.10M | $357.54B | 91.82% | 68 Neutral | |
| TSMC | 4.15% | $28.01M | $1.37T | 52.62% | 81 Outperform | |
| Novartis | 3.56% | $24.03M | $270.27B | 42.77% | 80 Outperform | |
| Sumitomo Mitsui | 3.30% | $22.27M | $127.51B | 39.56% | 76 Outperform | |
| Grupo Cibest | 3.19% | $21.49M | $17.71B | 116.85% | 71 Outperform | |
| ASML Holding | 3.04% | $20.52M | $468.07B | 61.61% | 81 Outperform | |
| AstraZeneca | 3.01% | $20.33M | $296.12B | 40.29% | 79 Outperform | |
| Barclays | 3.01% | $20.28M | $89.11B | 105.44% | 77 Outperform | |
| Embraer | 2.95% | $19.90M | $12.80B | 87.65% | 69 Neutral | |
| Southern Copper | 2.80% | $18.91M | $129.49B | 75.85% | 73 Outperform |